Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
DOCU-related Form 144 notice lists a proposed sale of 365 shares of Common stock associated with Morgan Stanley Smith Barney LLC, with a filing date of 06/02/2026 and a reported trade date of 05/29/2026. The filing also lists two prior dispositions in March 2026 of 363 and 365 shares, with reported amounts 16817.79 and 16432.30.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting a proposed sale of 450 shares of restricted common stock associated with James A. Beer. The restricted shares are dated 05/29/2026, and a prior sale of 450 shares is listed on 03/03/2026.
Trollope Rowan M reported acquisition or exercise transactions in this Form 4 filing.
DOCUSIGN, INC. director Rowan M. Trollope received a grant of 10,438 restricted stock units on May 8, 2026. Each RSU represents a contingent right to receive one share of DocuSign common stock.
The 10,438 RSUs will vest in twelve equal quarterly installments over three years, starting on May 2, 2026, as long as Trollope remains a service provider through each vesting date. The RSUs do not expire; they either vest into common shares or are canceled before vesting.
DOCUSIGN, INC. director Rowan M. Trollope has filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing lists him as a director but does not report any stock transactions or derivative holdings in the provided data.
Docusign, Inc. appointed Rowan Trollope to its board of directors as an independent Class III director, effective May 2, 2026. His term runs until the 2027 Annual Meeting of Stockholders and continues until a successor is elected and qualified or earlier departure.
Trollope is currently CEO and a board member of database services company Redis, Inc., and previously served as CEO and director of Five9, Inc. and in senior leadership roles at Cisco. He will receive standard board compensation under Docusign’s existing director program and enter into the company’s standard indemnity agreement. A press release dated May 6, 2026, announces his appointment.
Docusign Inc reports a passive >5% stake held by Vanguard Capital Management as of 03/31/2026. Vanguard Capital Management reports beneficial ownership of 10,756,040 shares, representing 5.53% of common stock and discloses sole dispositive power over 10,756,040 shares and sole voting power over 1,800,826 shares. The filing is a Schedule 13G signed on 04/29/2026.
Docusign Inc shows a 5.85% passive stake held by Vanguard Portfolio Management. Vanguard Portfolio Management reports beneficial ownership of 11,385,156 shares of Docusign common stock with sole dispositive power over those shares and sole voting power for 97,858 shares. The filing is a Schedule 13G signed 04/29/2026.
BlackRock, Inc. filed Amendment No. 2 reporting beneficial ownership of 20,722,495 shares of DocuSign common stock, representing 10.7% of the class. The filing attributes holdings to certain "Reporting Business Units" of BlackRock and shows sole voting power of 19,845,918 shares.